PHARMACODYNAMICS Which trails are your drugs taking?

被引:12
作者
Zhang, Rumin [1 ]
机构
[1] Merck Res Labs, Dept Pharmacol, Kenilworth, NJ 07065 USA
关键词
TARGET RESIDENCE TIME; BINDING-KINETICS; EFFICACY; SAFETY;
D O I
10.1038/nchembio.1795
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Binding kinetics (BK) has an indispensable role in pharmacodynamics (PD). Incorporating slow BK into a mechanistic PD model is shown to have predictive value for in vitro cellular and in vivo animal antibacterial efficacy.
引用
收藏
页码:382 / 383
页数:2
相关论文
共 9 条
[1]   The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety [J].
Copeland, Robert A. .
EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (04) :305-310
[2]   Understanding the Hysteresis Loop Conundrum in Pharmacokinetic/Pharmacodynamic Relationships [J].
Louizos, Christopher ;
Yanez, Jaime A. ;
Forrest, M. Laird ;
Davies, Neal M. .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (01) :34-91
[3]   A universal homogeneous assay for high-throughput determination of binding kinetics [J].
Schiele, Felix ;
Ayaz, Pelin ;
Fernandez-Montalvan, Amaury .
ANALYTICAL BIOCHEMISTRY, 2015, 468 :42-49
[4]   Biochemical mechanisms of new molecular entities (NMEs) approved by United States FDA during 2001-2004: Mechanisms leading to optimal efficacy and safety [J].
Swinney, David C. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (05) :461-478
[5]  
Swinney DC, 2008, PHARM MED, V22, P23, DOI 10.1007/BF03256679
[6]   Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time [J].
Vauquelin, Georges .
EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (10) :927-941
[7]  
Walkup G. K., 2015, NAT CHEM BIOL, DOI [10.1038/nchembio.1796, DOI 10.1038/NCHEMBI0.1796]
[8]  
Zhang Rumin, 2013, Methods Mol Biol, V1030, P59, DOI 10.1007/978-1-62703-484-5_6
[9]   Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs [J].
Zhang, Rumin ;
Monsma, Frederick .
EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (11) :1023-1029